Kintara Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KTRA and buy or sell other stocks, ETFs, and their options commission-free!About KTRA
TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm’s lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors.
CEOJames A. Bianco, MD
CEOJames A. Bianco, MD
Employees19
Employees19
HeadquartersTampa, Florida
HeadquartersTampa, Florida
Founded
Founded
Employees19
Employees19
KTRA Key Statistics
Market cap5.40M
Market cap5.40M
Price-Earnings ratio-0.34
Price-Earnings ratio-0.34
Dividend yield—
Dividend yield—
Average volume98.35K
Average volume98.35K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.93
52 Week high$7.93
52 Week low$1.80
52 Week low$1.80
Stock Snapshot
Kintara Therapeutics(KTRA) stock is priced at $0.12, giving the company a market capitalization of 5.4M. It carries a P/E multiple of -0.34.
During the trading day, Kintara Therapeutics(KTRA) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Kintara Therapeutics(KTRA) stock has reached 0, versus its average volume of 98.35K.
Over the past 52 weeks, Kintara Therapeutics(KTRA) stock has traded between a high of $7.93 and a low of $1.80.
Over the past 52 weeks, Kintara Therapeutics(KTRA) stock has traded between a high of $7.93 and a low of $1.80.
People also own
Based on the portfolios of people who own KTRA. This list is generated using Robinhood data, and it’s not a recommendation.